Several Blumberg Institute faculty and research staff recently participated in the 38thInternational Conference on Antiviral Research (ICAR) hosted by the International Society for Antiviral Research (ISAR), in Las Vegas.
Dimitar Gotchev, PhD, presented on “an Oral Hepatitis B Virus RNA Destabilizer to Suppress RNA and HBsAg”
Yanming Du, PhD, presented on “Identification of an in Vivo Effective Sulfamoylpyrrolamide Capsid Assembly Modulator (CAM) Against Hepatitis B Virus with Once-A-Day Oral Dosing in Mice”
David Renner, PhD, from Dr. Jinhong Chang’s laboratory, presented on “Kinetic Differences of Antiviral Reponses in Primary Versus Continuous Cell Lines in Antiviral Drug Development” and held a poster presentation on the preclinical work for the yellow fever antiviral compounds currently in preclinical development. David also participated in the annual PechaKucha contest
Sumangala Darsandhari, PhD and Jiaqi Li, MS, from Dr. Jinhong Chang’s laboratory, each presented a poster on yellow fever antiviral drug development
Jinhong Chang, PhD, received a special recognition at the closing ceremony for her 6 years of service as the Secretary of Board of Directors of ISAR and Nicholas Meanwell, PhD, distinguished professor at the Blumberg Institute, was awarded the 2024 Antonín Holý Memorial Award at the conference.
At ICAR, scientists working throughout the world in all areas of antiviral drug discovery and development meet in a collaborative and collegial atmosphere to report their most recent research and development progress. The Blumberg Institute is a proud sponsor of ICAR 2025.
Blumberg Institute faculty, Julianna Deakyne, associate director of nonclinical pharmacology and toxicology, recently attended the 64th Annual Society of Toxicology in Orlando, Florida.
Highlights of the event include:
Talks on physiologically relevant liver models, neurite growth models and placenta-on-a-chip technology. These talks emphasized the importance of incorporating flow, 3D compartments and immune-relevant components.
Integrated risk assessments to better characterize metabolites using multiple assays.
Quantitative in vitro to in vivo extrapolation to enhance confidence in predictions.
Several Blumberg Institute faculty and research staff recently participated in the 38th International Conference on Antiviral Research (ICAR) hosted by the International Society for Antiviral Research (ISAR), in Las Vegas.
Jinhong Chang, PhD, received a special recognition at the closing ceremony for her 6 years of service as the Secretary of Board of Directors of ISAR and Nicholas Meanwell, PhD, distinguished professor at the Blumberg Institute, was awarded the 2024 Antonín Holý Memorial Award at the conference.
At ICAR, scientists working throughout the world in all areas of antiviral drug discovery and development meet in a collaborative and collegial atmosphere to report their most recent research and development progress. The Blumberg Institute is a proud sponsor of ICAR 2025.
Blumberg Institute faculty, Julianna Deakyne, associate director of nonclinical pharmacology and toxicology, recently attended the 64th Annual Society of Toxicology in Orlando, Florida.
Highlights of the event include: